Searching genes encoding leishmania antigens for diagnosis and protection

Scholarly Research Exchange

Volumn , Issue , 2009, Pages

  Soto, Manuel ^a   Ramírez, Laura ^a   Pineda, Miguel A ^a   González, Victor M ^b   Entringer, Petter F ^c   De Oliveira, Camila Indiani ^c   Nascimento, Ivan P ^c   Souza, Ana P ^c   Corvo, Laura ^a   Alonso, Carlos ^a   Bonay, Pedro ^a   Brodskyn, Claudia ^c   Barral, Aldina ^c   Barral Netto, Manoel ^c   Iborra, Salvador ^d  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Ramon Y Cajal University   (Spain)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68149100493     PISSN: 16878299     EISSN: None     Source Type: Journal    
DOI: 10.3814/2009/173039     Document Type: Review

References (239)

1. Herwaldt B. L., Leishmaniasis The Lancet 1999 354 9185 1191 1199
2. Gramiccia M., Gradoni L., The current status of zoonotic leishmaniases and approaches to disease control International Journal for Parasitology 2005 35 11-12 1169 1180
3. Santos-Gomes G. M., Rosa R., Leandro C., Cortes S., Romo P., Silveira H., Cytokine expression during the outcome of canine experimental infection by Leishmania infantum Veterinary Immunology and Immunopathology 2002 88 1-2 21 30
4. Gradoni L., An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine Veterinary Parasitology 2001 100 1-2 87 103
5. McMahon-Pratt D., Alexander J., Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunological Reviews 2004 201 1 206 224
6. Schallig H. D. F. H., Oskam L., Molecular biological applications in the diagnosis and control of leishmaniasis and parasite identification Tropical Medicine and International Health 2002 7 8 641 651
7. Kar K., Serodiagnosis of leishmaniasis Critical Reviews in Microbiology 1995 21 2 123 152
8. Kubar J., Fragaki K., Recombinant DNA-derived Leishmania proteins: from the laboratory to the field The Lancet Infectious Diseases 2005 5 2 107 114
9. Coler R. N., Reed S. G., Second-generation vaccines against leishmaniasis Trends in Parasitology 2005 21 5 244 249
10. Handman E., Leishmaniasis: current status of vaccine development Clinical Microbiology Reviews 2001 14 2 229 243
11. Modabber F., Vaccines against leishmaniasis Annals of Tropical Medicine and Parasitology 1995 89 supplement 1 83 88
12. Greenblatt C. L., The present and future of vaccination for cutaneous leishmaniasis Progress in Clinical and Biological Research 1980 47 259 285
13. Kellina O. I., Problem and current lines in investigations on the epidemiology of leishmaniasis and its control in the U.S.S.R Bulletin de la Societe de Pathologie Exotique et de ses Filiales 1981 74 3 306 318
14. Palatnik C. B., Borojevic R., Previato J. O., Mendona-Previato L., Inhibition of Leishmania donovani promastigote internalization into murine macrophages by chemically defined parasite glycoconjugate ligands Infection and Immunity 1989 57 3 754 763
15. Palatnik-de-Sousa C. B., Gomes E. M., Paraguai-de-Souza E., Palatnik M., Luz K., Borojevic R., Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis Transactions of the Royal Society of Tropical Medicine and Hygiene 1995 89 4 390 393
16. Borja-Cabrera G. P., Da Silva V. O., Da Costa R. T., The fucose-mannose ligand-ELISA in the diagnosis and prognosis of canine visceral leishmaniasis in Brazil The American Journal of Tropical Medicine and Hygiene 1999 61 2 296 301
17. Parra L. E., Borja-Cabrera G. P., Santos F. N., Souza L. O. P., Palatnik-de-Sousa C. B., Menz I., Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil Vaccine 2007 25 12 2180 2186
18. Palatnik-de-Sousa C. B., Dutra H. S., Borojevic R., Leishmania donovani surface glycoconjugate GP36 is the major immunogen component of the Fucose-Mannose Ligand (FML) Acta Tropica 1993 53 1 59 72
19. Lemesre J.-L., Holzmuller P., Cavaleyra M., Gonalves R. B., Hottin G., Papierok G., Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes Vaccine 2005 23 22 2825 2840
20. Lemesre J.-L., Holzmuller P., Gonalves R. B., Long-lasting protection against canine visceral leishmaniasis using the Li ESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial Vaccine 2007 25 21 4223 4234
21. Rosa R., Rodrigues O. R., Marques C., Santos-Gomes G. M., Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response Experimental Parasitology 2005 109 2 106 114
22. Rosa R., Marques C., Rodrigues O. R., Santos-Gomes G. M., Immunization with Leishmania infantum released proteins confers partial protection against parasite infection with a predominant Th1 specific immune response Vaccine 2007 25 23 4525 4532
23. Button L. L., McMaster W. R., Molecular cloning of the major surface antigen of Leishmania Journal of Experimental Medicine 1988 167 2 724 729
24. Lohman K. L., Langer P. J., McMahon-Pratt D., Molecular cloning and characterization of the immunologically protective surface glycoprotein GP46/M-2 of Leishmania amazonensis Proceedings of the National Academy of Sciences of the United States of America 1990 87 21 8393 8397
25. Jardim A., Hanson S., Ullman B., McCubbin W. D., Kay C. M., Olafson R. W., Cloning and structure-function analysis of the Leishmania donovani kinetoplastid membrane protein-11 Biochemical Journal 1995 305, part 1 315 320
26. Clayton C. E., Life without transcriptional control? From fly to man and back again The EMBO Journal 2002 21 8 1881 1888
27. Donelson J. E., Gardner M. J., El-Sayed N. M., More surprises from Kinetoplastida Proceedings of the National Academy of Sciences of the United States of America 1999 96 6 2579 2581
28. Webb J. R., Campos-Neto A., Ovendale P. J., Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family Infection and Immunity 1998 66 7 3279 3289
29. Yahiaoui B., Loyens M., Taibi A., Schneck R., Dubremetz J. F., Ouaissi M. A., Characterization of a Leishmania antigen associated with cytoplasmic vesicles resembling endosomal-like structure Parasitology 1993 107, part 5 497 507
30. Murray P. J., Spithill T. W., Handman E., The PSA-2 glycoprotein complex of Leishmania major is a glycosylphosphatidylinositol-linked promastigote surface antigen The Journal of Immunology 1989 143 12 4221 4226
31. Quijada L., Requena J. M., Soto M., Mapping of the linear antigenic determinants of the Leishmania infantum Hsp70 recognized by leishmaniasis sera Immunology Letters 1996 52 2-3 73 79
32. Soto M., Requena J. M., Alonso C., Isolation, characterization and analysis of the expression of the Leishmania ribosomal PO protein genes Molecular and Biochemical Parasitology 1993 61 2 265 274
33. Soto M., Requena J. M., Garcia M., Gomez L. C., Navarrete I., Alonso C., Genomic organization and expression of two independent gene arrays coding for two antigenic acidic ribosomal proteins of Leishmania The Journal of Biological Chemistry 1993 268 29 21835 21843
34. Soto M., Requena J. M., Gomez L. C., Navarrete I., Alonso C., Molecular characterization of a Leishmania donovani infantum antigen identified as histone H2A European Journal of Biochemistry 1992 205 1 211 216
35. Soto M., Requena J. M., Morales G., Alonso C., The Leishmania infantum histone H3 possesses an extremely divergent N-terminal domain Biochimica et Biophysica Acta 1994 1219 2 533 535
36. Angel S. O., Requena J. M., Soto M., Criado D., Alonso C., During canine leishmaniasis a protein belonging to the 83-kDa heat-shock protein family elicits a strong humoral response Acta Tropica 1996 62 1 45 56
37. MacFarlane J., Blaxter M. L., Bishop R. P., Miles M. A., Kelly J. M., Identification and characterisation of a Leishmania donovani antigen belonging to the 70-kDa heat-shock protein family European Journal of Biochemistry 1990 190 2 377 384
38. Burns J. M. Jr., Scott J. M., Carvalho E. M., Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses The Journal of Immunology 1991 146 2 742 748
39. Skeiky Y. A., Guderian J. A., Benson D. R., A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12 Journal of Experimental Medicine 1995 181 4 1527 1537
40. Skeiky Y. A., Benson D. R., Guderian J. A., Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans Infection and Immunity 1995 63 10 4105 4114
41. Webb J. R., Kaufmann D., Campos-Neto A., Reed S. G., Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis The Journal of Immunology 1996 157 11 5034 5041
42. Santarm N., Silvestre R., Tavares J., Immune response regulation by Leishmania secreted and nonsecreted antigens Journal of Biomedicine and Biotechnology 2007 2007 10
43. Requena J. M., Alonso C., Soto M., Evolutionarily conserved proteins as prominent immunogens during Leishmania infections Parasitology Today 2000 16 6 246 250
44. Liew F. Y., ODonnell C. A., Immunology of Leishmaniasis Advances in Parasitology 1993 32 161 259
45. Requena J. M., Iborra S., Carrin J., Alonso C., Soto M., Recent advances in vaccines for leishmaniasis Expert Opinion on Biological Therapy 2004 4 9 1505 1517
46. Locksley R. M., Louis J. A., Immunology of leishmaniasis Current Opinion in Immunology 1992 4 4 413 418
47. Scott P., Caspar P., Sher A., Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes The Journal of Immunology 1990 144 3 1075 1079
48. Mougneau E., Altare F., Wakil A. E., Expression cloning of a protective Leishmania antigen Science 1995 268 5210 563 566
49. Probst P., Stromberg E., Ghalib H. W., Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning The Journal of Immunology 2001 166 1 498 505
50. Gurunathan S., Klinman D. M., Seder R. A., DNA vaccines: immunology, application, and optimization Annual Review of Immunology 2000 18 927 974
51. Smooker P. M., Rainczuk A., Kennedy N., Spithill T. W., DNA vaccines and their application against parasitespromise, limitations and potential solutions Biotechnology Annual Review 2004 10 189 236
52. Piedrafita D., Xu D., Hunter D., Harrison R. A., Liew F. Y., Protective immune responses induced by vaccination with an expression genomic library of Leishmania major The Journal of Immunology 1999 163 3 1467 1472
53. Melby P. C., Ogden G. B., Flores H. A., Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library Infection and Immunity 2000 68 10 5595 5602
54. Stober C. B., Lange U. G., Roberts M. T. M., From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine Leishmania major infection Vaccine 2006 24 14 2602 2616
55. Fasel N. J., Robyr D. C., Mauel J., Glaser T. A., Identification of a histone H1-like gene expressed in Leishmania major Molecular and Biochemical Parasitology 1993 62 2 321 324 (Pubitemid 24035965)
56. Coulson R. M. R., Smith D. F., Isolation of genes showing increased or unique expression in the infective promastigotes of Leishmania major Molecular and Biochemical Parasitology 1990 40 1 63 75
57. Charest H., Matlashewski G., Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene Molecular and Cellular Biology 1994 14 5 2975 2984
58. Yahiaoui B., Taibi A., Ouaissi A., A Leishmania major protein with extensive homology to silent information regulator 2 of Saccharomyces cerevisiae Gene 1996 169 1 115 118
59. Goto Y., Howard R. F., Bhatia A., Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs Veterinary Parasitology 2009 160 3-4 215 220
60. Frye R. A., Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins Biochemical and Biophysical Research Communications 2000 273 2 793 798
61. Gasser S. M., Cockell M. M., The molecular biology of the SIR proteins Gene 2001 279 1 1 16
62. Vergnes B., Sereno D., Madjidian-Sereno N., Lemesre J.-L., Ouaissi A., Cytoplasmic SIR2 homologue overexpression promotes survival of Leishmania parasites by preventing programmed cell death Gene 2002 296 1-2 139 150
63. Zemzoumi K., Sereno D., Franois C., Guilvard E., Lemesre J.-L., Ouaissi A., Leishmania major: cell type dependent distribution of a 43 kDa antigen related to silent information regulatory-2 protein family Biology of the Cell 1998 90 3 239 245
64. Silvestre R., Cordeiro-da-Silva A., Tavares J., Sereno D., Ouaissi A., Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies Immunology 2006 119 4 529 540
65. Cordeiro-da-Silva A., Cardoso L., Arajo N., Identification of antibodies to Leishmania silent information regulatory 2 (SIR2) protein homologue during canine natural infections: pathological implications Immunology Letters 2003 86 2 155 162
66. Santarm N., Toms A., Ouaissi A., Antibodies against a Leishmania infantum peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatment Immunology Letters 2005 101 1 18 23
67. Pimenta P. F. P., Saraiva E. M. B., Sacks D. L., The comparative fine structure and surface glycoconjugate expression of three life stages of Leishmania major Experimental Parasitology 1991 72 2 191 204
68. Ferguson M. A. J., The surface glycoconjugates of trypanosomatid parasites Philosophical Transactions of the Royal Society B 1997 352 1359 1295 1302
69. McConville M. J., Blackwell J. M., Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids The Journal of Biological Chemistry 1991 266 23 15170 15179
70. Bouvier J., Etges R. J., Bordier C., Identification and purification of membrane and soluble forms of the major surface protein of Leishmania promastigotes The Journal of Biological Chemistry 1985 260 29 15504 15509
71. Yao C., Donelson J. E., Wilson M. E., The major surface protease (MSP or GP63) of Leishmania sp. Biosynthesis, regulation of expression, and function Molecular and Biochemical Parasitology 2003 132 1 1 16
72. Etges R., Bouvier J., Bordier C., The major surface protein of Leishmania promastigotes is a protease The Journal of Biological Chemistry 1986 261 20 9098 9101
73. Bordier C., The promastigote surface protease of Leishmania Parasitology Today 1987 3 5 151 153
74. Bouvier J., Etges R., Bordier C., Identification of the promastigote surface protease in seven species of Leishmania Molecular and Biochemical Parasitology 1987 24 1 73 79
75. Okongo-Odera E. A., Kurtzhals J. A. L., Hey A. S., Kharazmi A., Measurement of serum antibodies against native Leishmania gp63 distinguishes between ongoing and previous L. donovani infection APMIS 1993 101 8 642 646
76. Shreffler W. G., Burns J. M. Jr., Badar R., Antibody responses of visceral leishmaniasis patients to gp63, a major surface glycoprotein of Leishmania species Journal of Infectious Diseases 1993 167 2 426 430
77. Morales G., Carrillo G., Requena J. M., Mapping of the antigenic determinants of the Leishmania infantum gp63 protein recognized by antibodies elicited during canine visceral leishmaniasis Parasitology 1997 114, part 6 507 516
78. Sanyal T., Ghosh D. K., Sarkar D., Immunoblotting identifies an antigen recognized by anti gp63 in the immune complexes of Indian kala-azar patient sera Molecular and Cellular Biochemistry 1994 130 1 11 17
79. Chakraborti T., Sarkar D., Ghosh D. K., Immune complex antigens as a tool in serodiagnosis of kala-azar Molecular and Cellular Biochemistry 2003 253 1-2 191 198
80. Mohareb E. W., Hanafi H. A., Mikhail E. M., Presley S. M., Batchelor R., Evaluation of an indirect immunofluorescence assay for the detection of Leishmania promastigotes and amastigotes in sand flies and lesion fluid aspirates Journal of the Egyptian Society of Parasitology 1998 28 2 313 321
81. Kahl L. P., Lelchuk R., Scott C. A., Beesley J., Characterization of Leishmania major antigen-liposomes that protect BALB/c mice against cutaneous leishmaniasis Infection and Immunity 1990 58 10 3233 3241
82. Russell D. G., Alexander J., Effective immunization cutaneous leishmaniasis with defined membrane antigens reconsituted into liposomes The Journal of Immunology 1988 140 4 1274 1279
83. Afrin F., Rajesh R., Anam K., Gopinath M., Pal S., Ali N., Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice Infection and Immunity 2002 70 12 6697 6706
84. Bhowmick S., Ravindran R., Ali N., gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani Infection and Immunity 2008 76 3 1003 1015
85. Jaafari M. R., Ghafarian A., Farrokh-Gisour A., Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice Vaccine 2006 24 29-30 5708 5717
86. Jaafari M. R., Badiee A., Khamesipour A., The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome Vaccine 2007 25 32 6107 6117
87. Yang D. M., Fairweather N., Button L. L., McMaster W. R., Kahl L. P., Liew F. Y., Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis The Journal of Immunology 1990 145 7 2281 2285
88. Abdelhak S., Louzir H., Timm J., Recombinant BCG expressing the Leishmania surface antigen gp63 induces protective immunity against Leishmania major infection in BALB/c mice Microbiology 1995 141, part 7 1585 1592
89. Connell N. D., Medina-Acosta E., McMaster W. R., Bloom B. R., Russell D. G., Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Gurin expressing the Leishmania surface proteinase gp63 Proceedings of the National Academy of Sciences of the United States of America 1993 90 24 11473 11477
90. Xu C. W., Hines J. C., Engel M. L., Russell D. G., Ray D. S., Nucleus-encoded histone H1-like proteins are associated with kinetoplast DNA in the trypanosomatid Crithidia fasciculata Molecular and Cellular Biology 1996 16 2 564 576
91. Frankenburg S., Axelrod O., Kutner S., Effective immunization of mice against cutaneous leishmaniasis using an intrinsically adjuvanted synthetic lipopeptide vaccine Vaccine 1996 14 9 923 929
92. Tsagozis P., Karagouni E., Dotsika E., Dendritic cells pulsed with peptides of gp63 induce differential protection against experimental cutaneous leishmaniasis International Journal of Immunopathology and Pharmacology 2004 17 3 343 352
93. McMahon-Pratt D., Traub-Cseko Y., Lohman K. L., Rogers D. D., Beverley S. M., Loss of the GP46/M-2 surface membrane glycoprotein gene family in the Leishmania braziliensis complex Molecular and Biochemical Parasitology 1992 50 1 151 160
94. Kahl L. P., McMahon-Pratt D., Structural and antigenic characterization of a species and promastigote-specific Leishmania mexicana amazonensis membrane protein The Journal of Immunology 1987 138 5 1587 1595
95. Maalej I. A., Chenik M., Louzir H., Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania antigens for the serodiagnosis of Mediterranean visceral leishmaniasis The American Journal of Tropical Medicine and Hygiene 2003 68 3 312 320
96. Boceta C., Alonso C., Jimnez-Ruiz A., Leucine rich repeats are the main epitopes in Leishmania infantum PSA during canine and human visceral leishmaniasis Parasite Immunology 2000 22 2 55 62
97. Handman E., Symons F. M., Baldwin T. M., Curtis J. M., Scheerlinck J.-P. Y., Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response Infection and Immunity 1995 63 11 4261 4267
98. Sjlander A., Baldwin T. M., Curtis J. M., Handman E., Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to Leishmaniasis The Journal of Immunology 1998 160 8 3949 3957
99. Sjlander A., Baldwin T. M., Curtis J. M., Bengtsson K. L., Handman E., Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection Vaccine 1998 16 20 2077 2084
100. Handman E., Noormohammadi A. H., Curtis J. M., Baldwin T., Sjlander A., Therapy of murine cutaneous leishmaniasis by DNA vaccination Vaccine 2000 18 26 3011 3017
101. Dumonteil E., Maria Jesus R.-S., Javier E.-O., Maria del Rosario G.-M., DNA vaccines induce partial protection against Leishmania mexicana Vaccine 2003 21 17-18 2161 2168
102. Dumonteil E., Andrade-Narvarez F., Escobedo-Ortegon J., Comparative study of DNA vaccines encoding various antigens against Leishmania mexicana Developments in Biologicals 2000 104 135 141
103. McMahon-Pratt D., Rodriguez D., Rodriguez J.-R., Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection Infection and Immunity 1993 61 8 3351 3359
104. Tolson D. L., Jardim A., Schnur L. F., The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation Infection and Immunity 1994 62 11 4893 4899
105. Jardim A., Funk V., Caprioli R. M., Olafson R. W., Isolation and structural characterization of the Leishmania donovani kinetoplastid membrane protein-11, a major immunoreactive membrane glycoprotein Biochemical Journal 1995 305, part 1 307 313
106. Berberich C., Requena J. M., Alonso C., Cloning of genes and expression and antigenicity analysis of the Leishmania infantum KMP-11 protein Experimental Parasitology 1997 85 1 105 108 (Pubitemid 27236722)
107. Ramrez J. R., Berberich C., Jaramillo A., Alonso C., Vlez I. D., Molecular and antigenic characterization of the Leishmania (Viannia) panamensis kinetoplastid membrane protein-11 Memrias do Instituto Oswaldo Cruz 1998 93 2 247 254
108. Jensen A. T. R., Gasim S., Ismail A., Humoral and cellular immune responses to synthetic peptides of the Leishmania donovani kinetoplastid membrane protein-11 Scandinavian Journal of Immunology 1998 48 1 103 109
109. Trujillo C., Ramrez R., Vlez I. D., Berberich C., The humoral immune response to the kinetoplastid membrane protein-11 in patients with American Leishmaniasis and Chagas disease: prevalence of IgG subclasses and mapping of epitopes Immunology Letters 2000 70 3 203 209
110. Passos S., de Carvalho L. P., Orge G., Recombinant Leishmania antigens for serodiagnosis of visceral leishmaniasis Clinical and Diagnostic Laboratory Immunology 2005 12 10 1164 1167
111. Jardim A., Tolson D. L., Turco S. J., Pearson T. W., Olafson R. W., The Leishmania donovani lipophosphoglycan T lymphocyte-reactive component is a tightly associated protein complex The Journal of Immunology 1991 147 10 3538 3544
112. Carrillo E., Crusat M., Nieto J., Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis Vaccine 2008 26 15 1902 1911
113. Basu R., Bhaumik S., Basu J. M., Naskar K., De T., Roy S., Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis The Journal of Immunology 2005 174 11 7160 7171
114. Ramrez J. R., Gilchrist K., Robledo S., Attenuated Toxoplasma gondii ts-4 mutants engineered to express the Leishmania antigen KMP-11 elicit a specific immune response in BALB/c mice Vaccine 2001 20 3-4 455 461
115. McKean P. G., Delahay R., Pimenta P. F. P., Smith D. F., Characterisation of a second protein encoded by the differentially regulated LmcDNA16 gene family of Leishmania major Molecular and Biochemical Parasitology 1997 85 2 221 231
116. Flinn H. M., Rangarajan D., Smith D. F., Expression of a hydrophilic surface protein in infective stages of Leishmania major Molecular and Biochemical Parasitology 1994 65 2 259 270
117. Alce T. M., Gokool S., McGhie D., Stger S., Smith D. F., Expression of hydrophilic surface proteins in infective stages of Leishmania donovani Molecular and Biochemical Parasitology 1999 102 1 191 196
118. Jensen A. T. R., Gasim S., Moller T., Serodiagnosis of Leishmania donovani infections: assessment of enzyme-linked immunosorbent assays using recombinant L. donovani gene B protein (GBP) and a peptide sequence of L. donovani GBP Transactions of the Royal Society of Tropical Medicine and Hygiene 1999 93 2 157 160
119. Stger S., Smith D. F., Kaye P. M., Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis The Journal of Immunology 2000 165 12 7064 7071
120. Moreno J., Nieto J., Masina S., Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis Vaccine 2007 25 29 5290 5300
121. Badar R., Benson D., Eullio M. C., rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis The Journal of Infectious Diseases 1996 173 3 758 761
122. Pollock K. G. J., McNeil K. S., Mottram J. C., The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses The Journal of Immunology 2003 170 4 1746 1753
123. Rafati S., Nakhaee A., Taheri T., Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis Experimental Parasitology 2003 103 3-4 143 151
124. Pateraki E., Portocala R., Labrousse H., Guesdon J. L., Antiactin and antitubulin antibodies in canine visceral leishmaniasis Infection and Immunity 1983 42 2 496 500
125. Zemzoumi K., Guilvard E., Sereno D., Cloning of a Leishmania major gene encoding for an antigen with extensive homology to ribosomal protein S3a Gene 1999 240 1 57 65
126. Skeiky Y. A. W., Benson D. R., Elwasila M., Badaro R., Burns J. M. Jr., Reed S. G., Antigens shared by Leishmania species and Trypanosoma cruzi: immunological comparison of the acidic ribosomal P0 proteins Infection and Immunity 1994 62 5 1643 1651
127. Montalvo-lvarez A. M., Folgueira C., Carrin J., Monzote-Fidalgo L., Caavate C., Requena J. M., The Leishmania HSP20 is antigenic during natural infections, but, as DNA vaccine, it does not protect BALB/c mice against experimental L. amazonensis infection Journal of Biomedicine and Biotechnology 2008 2008 9
128. Rey-Ladino J. A., Joshi P. B., Singh B., Gupta R., Reiner N. E., Leishmania major: molecular cloning, sequencing, and expression of the heat shock protein 60 gene reveals unique carboxy terminal peptide sequences Experimental Parasitology 1997 85 3 249 263
129. Quijada L., Requena J. M., Soto M., Alonso C., During canine viscero-cutaneous leishmaniasis the anti-Hsp70 antibodies are specifically elicited by the parasite protein Parasitology 1996 112, part 3 277 284
130. Larreta R., Soto M., Alonso C., Requena J. M., Leishmania infantum: gene cloning of the GRP94 homologue, its expression as recombinant protein, and analysis of antigenicity Experimental Parasitology 2000 96 2 108 115
131. Soto M., Requena J. M., Quijada L., Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis Clinical Experimental Immunology 1999 115 2 342 349
132. Rafati S., Salmanian A.-H., Hashemi K., Schaff C., Belli S., Fasel N., Identification of Leishmania major cysteine proteinases as targets of the immune response in humans Molecular and Biochemical Parasitology 2001 113 1 35 43
133. Khoshgoo N., Zahedifard F., Azizi H., Taslimi Y., Alonso M. J., Rafati S., Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals Vaccine 2008 26 46 5822 5829
134. Burns J. M. Jr., Shreffler W. G., Benson D. R., Ghalib H. W., Badaro R., Reed S. G., Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis Proceedings of the National Academy of Sciences of the United States of America 1993 90 2 775 779
135. Roberts M. T. M., Stober C. B., McKenzie A. N., Blackwell J. M., Interleukin-4 (IL-4) and IL-10 collude in vaccine failure for novel exacerbatory antigens in murine Leishmania major infection Infection and Immunity 2005 73 11 7620 7628
136. Cordeiro-da-Silva A., Borges M. C., Guilvard E., Ouaissi A., Dual role of the Leishmania major ribosomal protein S3a homologue in regulation of T- and B-cell activation Infection and Immunity 2001 69 11 6588 6596
137. Soto M., Requena J. M., Quijada L., Guzman F., Patarroyo M. E., Alonso C., Identification of the Leishmania infantum P0 ribosomal protein epitope in canine visceral leishmaniasis Immunology Letters 1995 48 1 23 28
138. Soto M., Requena J. M., Quijada L., During active viscerocutaneous leishmaniasis the anti-P2 humoral response is specifically triggered by the parasite P proteins Clinical Experimental Immunology 1995 100 2 246 252
139. Levin M. J., Vazquez M., Kaplan D., Schijman A. G., The Trypanosoma cruzi ribosomal P protein family: classification and antigenicity Parasitology Today 1993 9 10 381 384
140. Iborra S., Abnades D. R., Parody N., The immunodominant T helper 2 (Th2) response elicited in BALB/c mice by the Leishmania LiP2a and LiP2b acidic ribosomal proteins cannot be reverted by strong Th1 inducers Clinical Experimental Immunology 2007 150 2 375 385
141. Soto M., Alonso C., Requena J. M., The Leishmania infantum acidic ribosomal protein LiP2a induces a prominent humoral response in vivo and stimulates cell proliferation in vitro and interferon-gamma (IFN- ) production by murine splenocytes Clinical Experimental Immunology 2000 122 2 212 218
142. Soto M., Requena J. M., Quijada L., Alonso C., Specific serodiagnosis of human leishmaniasis with recombinant Leishmania P2 acidic ribosomal proteins Clinical and Diagnostic Laboratory Immunology 1996 3 4 387 391
143. Elkon K., Skelly S., Parnassa A., Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus Proceedings of the National Academy of Sciences of the United States of America 1986 83 19 7419 7423
144. Mayer C., Appenzeller U., Seelbach H., Humoral and cell-mediated autoimmune reactions to human acidic ribosomal P2 protein in individuals sensitized to Aspergillus fumigatus P2 protein Journal of Experimental Medicine 1999 189 9 1507 1512
145. Skeiky Y. A. W., Benson D. R., Parsons M., Elkon K. B., Reed S. G., Cloning and expression of Trypanosoma cruzi ribosomal protein P0 and epitope analysis of anti-P0 autoantibodies in Chagas disease patients Journal of Experimental Medicine 1992 176 1 201 211
146. Iborra S., Soto M., Carrin J., The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB/c mice Infection and Immunity 2003 71 11 6562 6572
147. Iborra S., Carrin J., Anderson C., Alonso C., Sacks D., Soto M., Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice Infection and Immunity 2005 73 9 5842 5852
148. Arndt E., Weigel C., Nucleotide sequence of the genes encoding the L11, L1, L10 and L12 equivalent ribosomal proteins from the archaebacterium Halobacterium marismortui Nucleic Acids Research 1990 18 5 1285 (Pubitemid 20106801)
149. Young D. B., Heat-shock proteins: immunity and autoimmunity Current Opinion in Immunology 1992 4 4 396 400
150. Folgueira C., Requena J. M., A postgenomic view of the heat shock proteins in kinetoplastids FEMS Microbiology Reviews 2007 31 4 359 377
151. Celeste B. J., Angel S. O., Castro L. G. M., Gidlund M., Goto H., Leishmania infantum heat shock protein 83 for the serodiagnosis of tegumentary leishmaniasis Brazilian Journal of Medical and Biological Research 2004 37 11 1591 1593
152. Gupta S. K., Sisodia B. S., Sinha S., Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes Proteomics 2007 7 5 816 823
153. Descoteaux A., Avila H. A., Zhang K., Turco S. J., Beverley S. M., Leishmania LPG3 encodes a GRP94 homolog required for phosphoglycan synthesis implicated in parasite virulence but not viability The EMBO Journal 2002 21 17 4458 4469
154. Larreta R., Guzman F., Patarroyo M. E., Alonso C., Requena J. M., Antigenic properties of the Leishmania infantum GRP94 and mapping of linear B-cell epitopes Immunology Letters 2002 80 3 199 205
155. Quijada L., Requena J. M., Soto M., Alonso C., Analysis of the antigenic properties of the L. infantum Hsp70: design of synthetic peptides for specific serodiagnosis of human leishmaniasis Immunology Letters 1998 63 3 169 174
156. Zurita A. I., Rodrguez J., Piero J. E., Cloning and characterization of the Leishmania (Viannia) braziliensis HSP70 gene. Diagnostic use of the C-terminal fragment rlb70(513663) Journal of Parasitology 2003 89 2 372 378
157. Echeverria P., Dran G., Pereda G., Analysis of the adjuvant effect of recombinant Leishmania infantum Hsp83 protein as a tool for vaccination Immunology Letters 2001 76 2 107 110
158. Rico A. I., Del Real G., Soto M., Characterization of the immunostimulatory properties of Leishmania infantum HSP70 by fusion to the Escherichia coli maltose-binding protein in normal and nu/nu BALB/c mice Infection and Immunity 1998 66 1 347 352
159. Rafati S., Gholami E., Hassani N., Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients Vaccine 2007 25 21 4159 4169
160. Webb J. R., Campos-Neto A., Skeiky Y. A. W., Reed S. G., Molecular characterization of the heat-inducible LmSTI1 protein of Leishmania major Molecular and Biochemical Parasitology 1997 89 2 179 193
161. Campos-Neto A., Porrozzi R., Greeson K., Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease Infection and Immunity 2001 69 6 4103 4108
162. Campos-Neto A., Webb J. R., Greeson K., Coler R. N., Skeiky Y. A. W., Reed S. G., Vaccination with plasmid DNA encoding TSA/LmSTI1 Leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice Infection and Immunity 2002 70 6 2828 2836
163. Badiee A., Jaafari M. R., Samiei A., Soroush D., Khamesipour A., Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice Clinical and Vaccine Immunology 2008 15 4 668 674
164. Soto M., Requena J. M., Quijada L., Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis Immunology Letters 1995 48 3 209 214
165. Soto M., Requena J. M., Quijada L., Characterization of the antigenic determinants of the Leishmania infantum histone H3 recognized by antibodies elicited during canine visceral leishmaniasis Clinical Experimental Immunology 1996 106 3 454 461
166. Montoya Y., Leon C., Talledo M., Recombinant antigens for specific and sensitive serodiagnosis of latin american tegumentary leishmaniasis transactions of the royal society of tropical medicine and hygiene 1997 91 6 674 676
167. de Carvalho L. P., Soto M., Jernimo S., Characterization of the immune response to Leishmania infantum recombinant antigens Microbes and Infection 2003 5 1 7 12
168. Iborra S., Soto M., Carrin J., Alonso C., Requena J. M., Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis Vaccine 2004 22 29-30 3865 3876
169. Carrin J., Nieto A., Soto M., Alonso C., Adoptive transfer of dendritic cells pulsed with Leishmania infantum nucleosomal histones confers protection against cutaneous leishmaniosis in BALB/c mice Microbes and Infection 2007 9 6 735 743
170. Carrin J., Folgueira C., Alonso C., Transitory or long-lasting immunity to Leishmania major infection: the result of immunogenicity and multicomponent properties of histone DNA vaccines Vaccine 2008 26 9 1155 1165
171. Carrin J., Folgueira C., Alonso C., Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells Vaccine 2008 26 20 2537 2544
172. Chenik M., Louzir H., Ksontini H., Dilou A., Abdmouleh I., Dellagi K., Vaccination with the divergent portion of the protein histone H2B of Leishmania protects susceptible BALB/c mice against a virulent challenge with Leishmania major Vaccine 2006 24 14 2521 2529
173. Smirlis D., Bisti S. N., Xingi E., Konidou G., Thiakaki M., Soteriadou K. P., Leishmania histone H1 overexpression delays parasite cell-cycle progression, parasite differentiation and reduces Leishmania infectivity in vivo Molecular Microbiology 2006 60 6 1457 1473
174. Papageorgiou F. T., Soteriadou K. P., Expression of a novel Leishmania gene encoding a histone H1-like protein in Leishmania major modulates parasite infectivity in vitro Infection and Immunity 2002 70 12 6976 6986
175. Solioz N., Blum-Tirouvanziam U., Jacquet R., The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis Vaccine 1999 18 9-10 850 859
176. Masina S., Gicheru M. M., Demotz S. O., Fasel N. J., Protection against cutaneous leishmaniasis in outbred vervet monkeys using a recombinant histone H1 antigen The Journal of Infectious Diseases 2003 188 8 1250 1257
177. McKerrow J. H., Sun E., Rosenthal P. J., Bouvier J., The proteases and pathogenicity of parasitic protozoa Annual Review of Microbiology 1993 47 821 853
178. Sakanari J. A., Nadler S. A., Chan V. J., Engel J. C., Leptak C., Bouvier J., Leishmania major: comparison of the cathepsin L- and B-like cysteine protease genes with those of other trypanosomatids Experimental Parasitology 1997 85 1 63 76
179. Mottram J. C., Brooks D. R., Coombs G. H., Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions Current Opinion in Microbiology 1998 1 4 455 460
180. Mottram J. C., Souza A. E., Hutchison J. E., Carter R., Frame M. J., Coombs G. H., Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors Proceedings of the National Academy of Sciences of the United States of America 1996 93 12 6008 6013
181. Buxbaum L. U., Denise H., Coombs G. H., Alexander J., Mottram J. C., Scott P., Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity The Journal of Immunology 2003 171 7 3711 3717
182. Alexander J., Bryson K., T helper (h)1/Th2 and Leishmania: paradox rather than paradigm Immunology Letters 2005 99 1 17 23
183. de Souza Dias S., da Costa Pinheiro P. H., Katz S., Machado dos Santos M. R., Barbiri C. L., A recombinant cysteine proteinase from Leishmania (Leishmania) chagasi suitable for serodiagnosis of American visceral leishmaniasis The American Journal of Tropical Medicine and Hygiene 2005 72 2 126 132
184. Pascalis H., Lavergne A., Bourreau E., Th1 cell development induced by cysteine proteinases A and B in localized cutaneous leishmaniasis due to Leishmania guyanensis Infection and Immunity 2003 71 5 2924 2926
185. Zadeh-Vakili A., Taheri T., Taslimi Y., Doustdari F., Salmanian A.-H., Rafati S., Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis Vaccine 2004 22 15-16 1930 1940
186. da Costa Pinheiro P. H., de Souza Dias S., Dantas Eullio K., Mendona I. L., Katz S., Barbiri C. L., Recombinant cysteine proteinase from Leishmania (Leishmania) chagasi implicated in human and dog T-cell responses Infection and Immunity 2005 73 6 3787 3789
187. Rafati S., Salmanian A.-H., Taheri T., Vafa M., Fasel N., A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major Vaccine 2001 19 25-26 3369 3375
188. Rafati S., Kariminia A., Seyde-Eslami S., Narimani M., Taheri T., Lebbatard M., Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8+ T lymphocyte activation Vaccine 2002 20 19-20 2439 2447
189. Rafati S., Zahedifard F., Nazgouee F., Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis Vaccine 2006 24 12 2169 2175
190. Rafati S., Nakhaee A., Taheri T., Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum Vaccine 2005 23 28 3716 3725
191. Poot J., Spreeuwenberg K., Sanderson S. J., Vaccination with a preparation based on recombinant cysteine peptidases and canine IL-12 does not protect dogs from infection with Leishmania infantum Vaccine 2006 24 14 2460 2468
192. Probst P., Skeiky Y. A. W., Steeves M., Gervassi A., Grabstein K. H., Reed S. G., A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor- production and expression of B7-1 in human monocyte-derived antigen-presenting cells European Journal of Immunology 1997 27 10 2634 2642
193. Skeiky Y. A. W., Kennedy M., Kaufman D., LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile The Journal of Immunology 1998 161 11 6171 6179
194. Borges M. M., Campos-Neto A., Sleath P., Potent stimulation of the innate immune system by a Leishmania brasiliensis recombinant protein Infection and Immunity 2001 69 9 5270 5277
195. Launois P., Maillard I., Pingel S., IL-4 rapidly produced by V 4 V 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice Immunity 1997 6 5 541 549
196. Gurunathan S., Sacks D. L., Brown D. R., Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major Journal of Experimental Medicine 1997 186 7 1137 1147
197. Julia V., Rassoulzadegan M., Glaichenhaus N., Resistance to Leishmania major induced by tolerance to a single antigen Science 1996 274 5286 421 423
198. Ben Hadj Ahmed S., Bahloul C., Robbana C., Askri S., Dellagi K., A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major Vaccine 2004 22 13-14 1631 1639
199. Soussi N., Saklani-Jusforgues H., Colle J.-H., Milon G., Glaichenhaus N., Goossens P. L., Effect of intragastric and intraperitoneal immunisation with attenuated and wild-type LACK-expressing Listeria monocytogenes on control of murine Leishmania major infection Vaccine 2002 20 21-22 2702 2712
200. Gonzalo R. M., Rodrguez J. R., Rodrguez D., Gonzlez-Aseguinolaza G., Larraga V., Esteban M., Protective immune response against cutaneous leishmaniasis by prime/booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36/LACK and IL-12 in combination with purified p36 Microbes and Infection 2001 3 9 701 711
201. Gonzalo R. M., del Real G., Rodriguez J. R., A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis Vaccine 2002 20 7-8 1226 1231
202. Prez-Jimnez E., Kochan G., Gherardi M. M., Esteban M., MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis Microbes and Infection 2006 8 3 810 822
203. Coelho E. A.F., Tavares C. A. P., Carvalho F. A. A., Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection Infection and Immunity 2003 71 7 3988 3994
204. Okuno T., Takeuchi M., Matsumoto Y., Otsuka H., Matsumoto Y., Pretreatment of Leishmania homologue of receptors for activated C kinase (LACK) promotes disease progression caused by Leishmania amazonensis Experimental Animals 2002 51 4 335 341
205. Pinto E. F., Pinheiro R. O., Rayol A., Larraga V., Rossi-Bergmann B., Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK Infection and Immunity 2004 72 8 4521 4527
206. Melby P. C., Yang J., Zhao W., Perez L. E., Cheng J., Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis Infection and Immunity 2001 69 8 4719 4725
207. Marques-da-Silva E. A., Coelho E. A.F., Gomes D. C. O., Intramuscular immunization with p36(LACK) DNA vaccine induces IFN- production but does not protect BALB/c mice against Leishmania chagasi intravenous challenge Parasitology Research 2005 98 1 67 74
208. Ramiro M. J., Zrate J. J., Hanke T., Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK Vaccine 2003 21 19-20 2474 2484
209. Ramos I., Alonso A., Marcen J. M., Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response Vaccine 2008 26 3 333 344
210. Dondji B., Prez-Jimenez E., Goldsmith-Pestana K., Esteban M., McMahon-Pratt D., Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis Infection and Immunity 2005 73 8 5286 5289
211. Zhang W.-W., Charest H., Ghedin E., Matlashewski G., Identification and overexpression of the A2 amastigote-specific protein in Leishmania donovani Molecular and Biochemical Parasitology 1996 78 1-2 79 90
212. Martins D. R. A., Jeronimo S. M. B., Donelson J. E., Wilson M. E., Leishmania chagasi T-cell antigens identified through a double library screen Infection and Immunity 2006 74 12 6940 6948
213. Ghedin E., Zhang W. W., Charest H., Sundar S., Kenney R. T., Matlashewski G., Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis Clinical and Diagnostic Laboratory Immunology 1997 4 5 530 535
214. Carvalho F. A. A., Charest H., Tavares C. A. P., Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen Diagnostic Microbiology and Infectious Disease 2002 43 4 289 295
215. Ghosh A., Labrecque S., Matlashewski G., Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response Vaccine 2001 19 23-24 3169 3178
216. Ghosh A., Zhang W. W., Matlashewski G., Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections Vaccine 2001 20 1-2 59 66
217. Fernandes A. P., Costa M. M. S., Coelho E. A. F., Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein Vaccine 2008 26 46 5888 5895
218. Guimares Carvalho S. F., Lemos E. M., Corey R., Dietze R., Performance of recombinant K39 antigen in the diagnosis of Brazilian visceral leishmaniasis The American Journal of Tropical Medicine and Hygiene 2003 68 3 321 324
219. Medrano F. J., Caavate C., Leal M., Rey C., Lissen E., Alvar J., The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type- 1 The American Journal of Tropical Medicine and Hygiene 1998 59 1 155 162 (Pubitemid 28304814)
220. Singh S., Kumari V., Singh N., Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen Clinical and Diagnostic Laboratory Immunology 2002 9 3 568 572
221. Veeken H., Ritmeijer K., Seaman J., Davidson R., Comparison of an rK39 dipstick rapid test with direct agglutination test and splenic aspiration for the diagnosis of kala-azar in Sudan Tropical Medicine International Health 2003 8 2 164 167
222. Zijlstra E. E., Nur Y., Desjeux P., Khalil E. A. G., El-Hassan A. M., Groen J., Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan Tropical Medicine International Health 2001 6 2 108 113
223. Porrozzi R., Santos da Costa M. V., Teva A., Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs Clinical and Vaccine Immunology 2007 14 5 544 548
224. Toz S. O., Chang K.-P., Ozbel Y., Alkan M. Z., Diagnostic value of RK39 dipstick in zoonotic visceral leishmaniasis in Turkey Journal of Parasitology 2004 90 6 1484 1486
225. da Costa R. T., Frana J. C., Mayrink W., Nascimento E., Genaro O., Campos-Neto A., Standardization of a rapid immunochromatographic test with the recombinant antigens K39 and K26 for the diagnosis of canine visceral leishmaniasis Transactions of the Royal Society of Tropical Medicine and Hygiene 2003 97 6 678 682
226. Otranto D., Paradies P., Sasanelli M., Recombinant K39 dipstick immunochromatographic test: a new tool for the serodiagnosis of canine leishmaniasis Journal of Veterinary Diagnostic Investigation 2005 17 1 32 37
227. Dey A., Sharma P., Redhu N. S., Singh S., Kinesin motor domain of Leishmania donovani as a future vaccine candidate Clinical and Vaccine Immunology 2008 15 5 836 842
228. Belkaid Y., Mendez S., Lira R., Kadambi N., Milon G., Sacks D., A natural model of Leishmania major infection reveals a prolonged silent phase of parasite amplification in the skin before the onset of lesion formation and immunity The Journal of Immunology 2000 165 2 969 977
229. Mndez S., Gurunathan S., Kamhawi S., The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge The Journal of Immunology 2001 166 8 5122 5128
230. Fujiwara R. T., Vale A. M., Frana da Silva J. C., Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis Veterinary Research 2005 36 5-6 827 838
231. Skeiky Y. A. W., Coler R. N., Brannon M., Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant Vaccine 2002 20 27-28 3292 3303
232. Coler R. N., Skeiky Y. A. W., Bernards K., Immunization with a polyprotein vaccine consisting of the T-cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis Infection and Immunity 2002 70 8 4215 4225
233. Coler R. N., Goto Y., Bogatzki L., Raman V., Reed S. G., Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4+ T cells Infection and Immunity 2007 75 9 4648 4654
234. Boarino A., Scalone A., Gradoni L., Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis Clinical and Diagnostic Laboratory Immunology 2005 12 5 647 653
235. Soto M., Requena J. M., Quijada L., Alonso C., Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis Journal of Clinical Microbiology 1998 36 1 58 63
236. Parody N., Soto M., Requena J. M., Alonso C., Adjuvant guided polarization of the immune humoral response against a protective multicomponent antigenic protein (Q) from Leishmania infantum. A CpG + Q mix protects Balb/c mice from infection Parasite Immunology 2004 26 6-7 283 293
237. Molano I., Garca Alonso M., Mirn C., A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum Veterinary Immunology and Immunopathology 2003 92 1-2 1 13
238. Chang K.-P., McGwire B. S., Molecular determinants and regulation of Leishmania virulence Kinetoplastid Biology and Disease 2002 1, article 1 1 7
239. Chang K.-P., Reed S. G., McGwire B. S., Soong L., Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity Acta Tropica 2003 85 3 375 390